Author:
Wang Tingting,Zhao Ting,Bao Sichen,Jia Li,Feng Jie,Yu Aiping,Sun Li,Guo Xihong,Li Hongjian,Yu Luhai
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference40 articles.
1. Association between ErbB3 genetic polymorphismsand coronary artery disease in the Han and Uygur populations of China;Maitusong;Int J Clin Exp Med,2015
2. Genetic polymorphisms of the drug-metabolizing enzyme CYP2C19 in the Uygur population in northwest China;Jin;Xenobiotica,2015
3. Appropriate LDL-C-to-HDL-C ratio cutoffs for categorization of cardiovascular disease risk factorsamong uygur adults in Xinjiang, China;Chen;Int J Environ Res Public Health,2016
4. Paraoxonase-1 is a major determinant of clopidogrel efficacy;Bouman;Nat Med,2011
5. Effect of clinical factors and genepolymorphisms of CYP2C19∗2,∗17 andCYP4F2∗3 on early stent thrombosis;Kupstyte;Pharmacogenomics,2015
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effect of pharmacogenomics - oriented Dual Antiplatelet Therapy Followed by P2Y12 receptor inhibitors/Aspirin on Cardiovascular and Bleeding Events in ACS Patients: A Trial Protocol;2024-06-12
2. CYP2C19 *2/*2 Genotype is a Risk Factor for Multi-Site Arteriosclerosis: A Hospital-Based Cohort Study;International Journal of General Medicine;2023-11
3. The Cytochrome P450 2C19 Polymorphism Associated with Major Adverse
Cardiovascular Events Risk in Kazak Patients Undergoing Percutaneous
Coronary Intervention and Receiving Clopidogrel;Endocrine, Metabolic & Immune Disorders - Drug Targets;2023-02
4. Prevalence of dyslipidemia and gene polymorphisms of ABCB1 and SLCO1B1 in Han, Uygur, Kazak, Hui, Tatar, Kirgiz, and Sibe populations with coronary heart disease in Xinjiang, China;Lipids in Health and Disease;2021-09-25
5. The effects of polymorphisms in CYP2C19, ATP-binding cassette transporter B1, and paraoxonase-1 on clopidogrel treatment of Uygur patients following percutaneous coronary intervention;European Journal of Clinical Pharmacology;2021-06-23